Hologic, a
leading global healthcare and diagnostics company continues to expand its
Breast Health portfolio through continued innovation and product development. As
a breakthrough, FDA recently approved its Genius 3D Tomosynthesis Mammography
as the only test superior to 2D mammography for routine breast cancer
screening.
The Genius
exams is available to public since 2011, but the newly approved labeling comes
in wake of results of clinical studies showing “the exam improves invasive
breast cancer detection while reducing unnecessary recalls among women of all
breast densities, including those with dense breasts,” according to press release by Hologic.
To find out
who offers Genius 3D mammography in your area in USA, click here.
Among women
between the age of 40 to 74 years, nearly 40% to 50% have dense breast. Dense
breast also increases the likelihood of developing cancer by 5 to 6 times as
compared to women with normal breast density.
Often the cancers are detected very late in women with dense tissue
because of imaging difficulty.
Density of
breast is a measure of amount of fibrous or glandular tissue in breast and can
only be identified by imaging techniques. To make patients aware about it, 31
states in US requires notification to be sent to patients after a mammogram.
"Radiologists
and referring physicians needed an answer for how to screen the roughly half of
women with dense breasts, because until now, this patient population was
confused and frustrated without a clear path forward," said Pete Valenti,
Hologic's Division President, Breast and Skeletal Health Solutions. "We
are pleased today to provide this definitive guidance from the FDA that the
Genius exam is a superior screening solution for women with dense breasts. This
is yet another reason referring physicians can feel confident in recommending
Hologic's Genius exam."
Although Conventional
2D mammography is currently the gold standard, it has limitations in women with
dense breast because the dense tissue can overlay on top of each other and
potentially hide small cancers.
The main
advantage of 3D tomosynthesis is it can clearly delineate the underlying breast
tissue, irrespective of breast density. This
enables the diagnosis at very early stage and reduces false positives results,
thereby avoiding unnecessary biopsy.
It is also a
method of choice in women who are at high risk for developing cancer or women
who are referred for breast lump.
Another
screening modality for women with dense breast is Innovative Breast Ultrasound
system: the Invenia Automated Breast Ultrasound System(ABUS).
To get
information on personalized breast screening click here
Here is a
video by Hologic about how Genius 3D mammography is performed.
No comments:
Post a Comment